Therapeutic Potential of Nerve Growth Factors in Parkinson??s Disease
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 14 (4) , 261-287
- https://doi.org/10.2165/00002512-199914040-00003
Abstract
Parkinson’s disease (PD) is a neurodegenerative syndrome which primarily affects dopamine-producing neurons of the substantia nigra, resulting in poverty and slowness of movement, instability of gait...Keywords
This publication has 97 references indexed in Scilit:
- Differential distribution of exogenous BDNF, NGF, and NT‐3 in the brain corresponds to the relative abundance and distribution of high‐affinity and low‐affinity neurotrophin receptorsJournal of Comparative Neurology, 1995
- Nerve growth factor in Alzheimerʼs disease: defective retrograde transport to nucleus basalisNeuroReport, 1995
- Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in ratDevelopmental Brain Research, 1995
- Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivoNeuroscience Letters, 1994
- The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitroDevelopmental Brain Research, 1994
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in cultureDevelopmental Biology, 1989
- Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated miceLife Sciences, 1989
- Treatment with GM1 Ganglioside Restores Striatal Dopamine in the 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated MouseJournal of Neurochemistry, 1988
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988